• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Omthera Pharmaceuticals Inc

4OP:GR

Ticker Delisted

Snapshot for Omthera Pharmaceuticals Inc (4OP)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for 4OP

No chart data available.
  • 4OP:GR
  • 1M
  • 1Y
0.000
Interactive 4OP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4OP

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2013) -1.0260
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4OP

No data available

Company Profile & Key Executives for 4OP

Omthera Pharmaceuticals, Inc. provides pharmaceutical products and therapies. The Company develops new therapies for abnormalities in blood lipids, dyslipidemia, and cardiovascular diseases. Omthera Pharmaceuticals serves patients worldwide.

Gerald L Wisler "Jerry"President/CEO/Co-FounderChristian S Schade "Chris"Exec VP/CFO
Bernardus N MachielseExec VP/COOMichael H DavidsonExec VP/Chief Medical Officer
More Company Profile & Key Executives for 4OP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil